05-07-2008

Dergi Hakkında
Yayın Kurulu
Uluslararası Danışmanlar
İstatistik ve Epidemiyoloji Danışmanları
Ulusal Danışmanlar
Yazım Kuralları
Yayın Hakları Devir Formu
Online Makale İşlemleri
İletişim
Tıp Bilimleri Dergisi
ISSN: 1300-0292
İndekslendiği Dizinler: SCIENCE CITATION INDEX EXPANDED
CINAHL, Index Copernicus,
Chemical Abstracts (CA),
Excerpta Medica / EMBASE
Dil: Türkçe, İngilizce
İçerik: Orijinal Araştırma, Derleme, Editöre Mektup, Olgu Sunumu, Tıp Eğitimi, Tıbbi Kitap İncelemeleri

 

ORIGINAL RESEARCH ARTICLES


Obesity And Inflammation

Dr. Serkan KESKİN,a Dr. Erhan SAYALI,a Dr. Ela TEMELOĞLU,a Dr. İsmail EKİZOĞLUa

a2. Dahiliye Kliniği, Taksim Eğitim ve Araştırma Hastanesi, İSTANBUL



Objective: Obesity is a major health problem in developed countries. The etio-pathogenesis of obesity has long been a matter of speculation and study. In recent years researchers have focused on the role of inflammation in obesity. It has been shown that CRP, an acute phase reactant, is elevated in a great number of diseases. In our study we evaluated CRP and fibrinogen in obese and non-obese subjects.
Material and Methods: Thirty-two male and 82 female subjects participated in our study. Their body mass index (BMI) was measured and, after 12 hours of fasting, blood samples were taken for CRP, fibrinogen, ESR, glucose, total cholesterol, triglyceride, HDL, VLDL and LDL-cholesterol levels. Correlations between BMI and the results of the above mentioned analyses were examined.
Results: Of the subjects participating in our study, 32 (28%) were male, 82 (72%) were female. No difference for BMI, CRP and fibrinogen levels was observed between male and female subjects (p> 0.05). HDL-cholesterol levels were 56.45 ± 15.66 mg/dL in female subjects and 41.45 ± 9.47 mg/dL in males (p= 0.0001, t=
-4.98). Subjects were divided in 3 groups according to their BMI: <25, 25-30, ≥30 kg/m2. CRP levels were 2.30 ± 1.98, 4.03 ± 3.62 and 4.71 ± 4.50 mg/L, respectively, in these groups (p= 0.028, F= 3.72). Fibrinogen levels were, respectively, 303.98 ± 54.12, 337.25 ± 78.23 and 347.68 ± 96.52 mg/dL (p= 0.044, F= 3.24).
Conclusion: As body mass index increases, levels of inflammatory mediators increase. This silent inflammation causes several complications and adds to the sequelae of obesity. Whether such inflammation is the cause or result of obesity and whether obesity may be influenced by anti inflammatory therapy remains to be determined.


Keywords: Obesity, inflammation, body mass index, C-reactive protein

Turkiye Klinikleri J Med Sci 2005, 25:636-641

E-mail To Friend This Page Printer Friendly Page
 
 
 ARAMA
  
 Ayrıntılı Arama
 GİRİŞ
 Kullanıcı Adı :
 
 Şifre  
   Beni Hatırla
 Şifremi Unuttum
 Kayıt Ol
 
 
 
 
 
 
 
 

Yasal uyarı: Bu sitede yayınlanan resim, yazı ve diğer uygulamaların her hakkı Ortadoğu Reklam Ve Yayıncılık A.Ş. 'ye aittir. Kaynak gösterilmeden kullanılamaz. Bu site hekimleri sağlık alanında bilgilendirmeye yönelik hazırlanmıştır. Sitede yer alan bilgiler tanı ve tedavi amaçlı kullanıldığında sorumluluk tamamen kullanıcıya aittir. Siteye girmekle bu şartları okumuş, anlamış ve kabul etmiş sayılırsınız.